Erdosteine modulates radiocontrast-induced hepatotoxicity in rat

Cell Biochemistry and Function

Volumn 27, Issue 3, 2009, Pages 142-147

  Yesildaǧ, Ahmet ^a   Özden, Ahmet ^a   Yilmaz, H Ramazan ^a   Uz, Efkan ^a   Aǧackiran, Yetkin ^b   Yesildaǧ, Mihrican ^c   Yilmaz, Nigar ^a   Sirmali, Rana ^a   Vural, Hüseyin ^a   Naziroǧlu, Mustafa ^d  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b ANKARA OCCUPATIONAL DISEASES HOSPITAL   (Turkey)

^c ISPARTA STATE HOSPITAL   (Turkey)

^d SULEYMAN DEMIREL UNIVERSITY   (Turkey)

Author keywords

Erdosteine; Hepatotoxicity; Malondialdehyde; Radiocontrast; Reactive oxygen species

Indexed keywords

CATALASE; ERDOSTEINE; MALONALDEHYDE; MEGLUMINE DIATRIZOATE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER PROTECTION; LIVER TOXICITY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; TISSUE DISTRIBUTION; WISTAR RAT;

ANIMALS; CATALASE; CONTRAST MEDIA; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDATION; LIVER; LIVER DISEASES; MALE; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; THIOGLYCOLATES; THIOPHENES;

RATTUS;

EID: 65549123743     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1546     Document Type: Article

References (35)

1. Naziroǧlu M. New molecular mechanisms on the activation of TRPM2 channels by oxidative stress and ADP-ribose. Neurochem Res 2007; 32: 1990-2001.
2. Sahin M, Cam H, Olgar S, et al. Protective role of erdosteine on vancomycin-induced oxidative stress in rat liver. Mol Cell Biochem 2006; 291: 155-160.
3. Naziroǧlu M, Çay M, Üstündag. B, et al. Protective effects of vitamin E on carbon tetrachloride-induced liver damage in rats. Cell Biochem Funct 1999; 17: 253-259.
4. Kaya H, Koc A, Sogut S, et al. The protective effect of N-acetylcysteine against cyclosporine A-induced hepatotoxicity in rats. J Appl Toxicol 2008; 28: 15-20.
5. Yilmaz HR, Songur A, Ozyurt B, Zararsiz I, Sarsilmaz M. The effects of n-3 polyunsaturated fatty acids by gavage on some metabolic enzymes of rat liver. Prostaglandins Leukot Essent Fatty Acids 2004; 71: 131-135.
6. Zager RA, Johnson AC, Hanson SY. Radiographic contrast mediainduced tubular injury: evaluation of oxidant stress and plasma membrane integrity. Kidney Int 2003; 64: 128-139.
7. Haeussler U, Riedel M, Keller F. Free reactive oxygen species and nephrotoxicity of contrast agents. Kidney Blood Press Res 2004; 27: 167-171.
8. Klause N, Arendt T, Lins M, Gronow G. Hypoxic renal tissue damage by endothelin-mediated arterial vasoconstriction during radioangiography in man. Adv Exp Med Biol. 1998; 454: 225-234.
9. Bátkai S, Osei-Hyiaman D, Pan H, et al. Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury. FASEB J 2007; 21: 1788-1800.
10. Drager LF, Andrade L, Barros de Toledo JF, et al. Renal effects of Nacetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. Nephrol Dial Transplant 2004; 19: 1803-1807.
11. Zager RA, Johnson ACM, Hanson SY. Radiographic contrast mediainduced tubular injury: Evaluation of oxidant stress and plasma membrane integrity. Kidney Int 2003; 64: 128-139.
12. Lee HT, Jan M, Bae SC, et al. A1 adenosine receptor knockout mice are protected against acute radiocontrast nephropathy in vivo. Am J Physiol Renal Physiol 2006; 290: F1367-F1375.
13. Sirmali M, Uz E, Sirmali R, et al. Protective effects of erdosteine and vitamins C and E combination on ischemia-reperfusion-induced lung oxidative stress and plasma copper and zinc levels in a rat hind limb model. Biol Trace Elem Res 2007; 118: 43-52.
14. Oktem F, Arslan MK, Ozguner F, et al. In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine. Toxicology 2005; 215: 227-233.
15. Ozyurt H, Yildirim Z, Kotuk M, Yilmaz HR, Yaǧmurca M, Iraz M, Sögüt S, Gergerlioglu S. Cisplatin-induced acute renal failure is ameliorated by erdosteine in a dose-dependent manner. J Appl Toxicol 2004; 24: 269-275.
16. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990; 186: 421-431.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with folin phenol reagent. J Clin Chem 1951; 193: 265-269.
18. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1998; 34: 497-500.
19. Aebi Y. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.
20. Sedlak J, Lindsay RHC. Estimation of total, protein bound and nonprotein sulfhydryl groups in tissue with Ellmann's reagent. Anal Biochem 1968; 25: 192-205.
21. Özmen I, Naziroǧlu M, Alici HA, et al. Spinal morphine administration reduces the fatty acid contents in spinal cord and brain in rabbits due to oxidative stress. Neurochem Res 2007; 32: 19-25.
22. Lawrence RA, Burk RF. 1976; Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 1976; 71: 952-958.
23. Jee RC, Sipes RI, Gandolfi J, Brown BR. Facors influencing halothane hepatotoxicity in the hypoxic rat model. Toxicol Appl Pharmacol 1980; 52: 267-277.
24. Bakris GL, Lass N, Gaber AO, Jones JD, Burnett JC Jr. Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. Am J Physiol 1990; 258(1 Pt 2): F115-F1120.
25. Dal Sasso M, Culici M, Guffanti EE, et al. A combination of budesonide and the SH-metabolite I of erdosteine acts synergistically in reducing chemiluminescence during human neutrophil respiratory burst. Pharmacology 2005; 74: 127-134.
26. Sogut S, Ozyurt H, Armutcu F, et al. Erdosteine prevents bleomycin-induced pulmonary fibrosis in rats. Eur J Pharmacol 2004; 494: 213-220.
27. Sener G, Aksoy H, Sehirli O, et al. Erdosteine prevents colonic inflammation through its antioxidant and free radical scavenging activities. Dig Dis Sci 2007; 52: 2122-2132.
28. Yagmurca M, Bas O, Mollaoglu H, et al. Protective effects of erdosteine on doxorubicininduced hepatotoxicity in rats. Arch Med Res 2007; 38: 380-385.
29. Kuvandik G, Duru M, Nacar A, et al. Effects of erdosteine on acetaminophen-induced hepatotoxicity in rats. Toxicol Pathol 2008; 36: 714-719.
30. Ozerol E, Bilgic S, Iraz M, et al. The protective effect of erdosteine on short-term global brain ischemia/reperfusion injury in rats. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33(1): 20-24.
31. Islekel S, Islekel H, Guner G, Ozdamar N. Alterations in superoxide dismutase, glutathione peroxidase and catalase activities in experimental cerebral ischemia-reperfusion. Res Exp Med (Berlin) 1999; 199: 167-176.
32. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr 2004; 134: 489-492.
33. Arthur JR, McKenzie RC, Beckett GJ. Selenium in the immune system. J Nutr 2003; 135(Suppl. 1); 1457s-1459s.
34. Seekamp A, Ward PA. Ischemia-reperfusion injury. Agents Actions 1993; 41 (Suppl.): 137-152.
35. Dal Sasso M, Culici M, Guffanti EE, et al. A combination of budesonide and the SH-metabolite I of erdosteine acts synergistically in reducing chemiluminescence during human neutrophil respiratory burst. Pharmacology 2005; 74: 127-134.